Low Evidence
Research Overview
5-Amino-1MQ Research for Metabolic Syndrome
An evidence-based overview of research examining 5-Amino-1MQ in the context of metabolic syndrome. This page synthesizes findings from peer-reviewed literature.
Research Summary
Preclinical studies show NNMT inhibition improves insulin sensitivity and glucose tolerance in mice. Human observational data shows NNMT expression correlates with insulin resistance. Translation to metabolic syndrome treatment remains unproven.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Metabolic Syndrome
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. 5-Amino-1MQ has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.